Tennessee § 63-10-502 Part definitions

Tennessee Statutes

§ 63-10-502 — Part definitions

Tennessee § 63-10-502

Title63

This text of Tennessee § 63-10-502 (Part definitions) is published on Counsel Stack Legal Research, covering Tennessee primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Tenn. Code Ann. § 63-10-502 (2026).

Text

As used in this part:

(1)"Anti-rejection drug" means a prescription drug that suppresses the immune system to prevent or reverse rejection of a transplanted organ;

(2)"Board" means the board of pharmacy;

(3)"Cancer drug" means a prescription drug that is used to treat:

(A)Cancer or the side effects of cancer; or (B) The side effects of a prescription drug that is used to treat cancer or the side effects of cancer;

(4)"Controlled substance" has the same meaning as defined in § 39-17-402 ;

(5)"Department" means the department of health;

(6)"Donor" means any of the following that donates prescription drugs to a repository program approved pursuant to this part:

(A)A person;

(B)A pharmacy;

(C)A medical facility;

(D)A drug manufacturer or wholesaler licensed by the board; or (E) A pr

Free access — add to your briefcase to read the full text and ask questions with AI

As used in this part: (1) "Anti-rejection drug" means a prescription drug that suppresses the immune system to prevent or reverse rejection of a transplanted organ; (2) "Board" means the board of pharmacy; (3) "Cancer drug" means a prescription drug that is used to treat: (A) Cancer or the side effects of cancer; or (B) The side effects of a prescription drug that is used to treat cancer or the side effects of cancer; (4) "Controlled substance" has the same meaning as defined in § 39-17-402 ; (5) "Department" means the department of health; (6) "Donor" means any of the following that donates prescription drugs to a repository program approved pursuant to this part: (A) A person; (B) A pharmacy; (C) A medical facility; (D) A drug manufacturer or wholesaler licensed by the board; or (E) A prison or government entity federally authorized to possess prescription drugs with a license or permit in good standing in the state in which the entity is located; (7) "Eligible individual" means an indigent, an uninsured person, or an underinsured person who meets the criteria for eligibility pursuant to this part; (8) "Indigent" means a person with an income that is below six hundred percent (600%) of the federal poverty level as defined by the most recently revised poverty income guidelines published by the United States department of health and human services; (9) "Medical facility" means: (A) A physician's office; (B) A hospital; (C) A health clinic; (D) A nonprofit health clinic, including a federally qualified health center as defined in 42 U.S.C. § 1396d(l)(2)(B) ; a rural health clinic, as defined in 42 U.S.C. § 1396d(l)(1) ; and a nonprofit health clinic that provides medical care to patients who are indigent, uninsured, or underinsured; (E) A free clinic as defined in § 63-6-703 ; (F) A charitable organization as defined in § 48-101-501 ; or (G) A nursing home as defined in § 68-11-201 ; (10) "Pharmacy" means a pharmacy as defined in § 63-10-204 ; (11) "Prescription drug": (A) Has the same meaning as defined in § 63-10-204 ; (B) Includes, but is not limited to, cancer drugs and anti-rejection drugs; and (C) Does not include: (i) Controlled substances; or (ii) Drugs covered by the risk evaluation and mitigation strategy program of the United States food and drug administration; (12) "Repository" means a pharmacy that: (A) Has a license or permit in good standing with the board; and (B) Meets the requirements established by § 63-10-503 ; (13) "Supplies" means the supplies necessary to administer the prescription drugs donated pursuant to this part; and (14) "Unopened tamper-evident packaging" has the same meaning as defined in United States Pharmacopeia (USP) General Chapter 659, Packaging and Storage Requirements.